These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30369686)

  • 1. Medical isotope production, research reactors and their contribution to the global xenon background.
    Hoffman I; Berg R
    J Radioanal Nucl Chem; 2018; 318(1):165-173. PubMed ID: 30369686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting the baseline for estimated background observations at IMS systems of four radioxenon isotopes in 2014.
    Gueibe C; Kalinowski MB; Baré J; Gheddou A; Krysta M; Kusmierczyk-Michulec J
    J Environ Radioact; 2017 Nov; 178-179():297-314. PubMed ID: 28942373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere.
    Saey PR; Auer M; Becker A; Hoffmann E; Nikkinen M; Ringbom A; Tinker R; Schlosser C; Sonck M
    J Environ Radioact; 2010 Sep; 101(9):730-8. PubMed ID: 20554098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of temporary radioxenon background measurement campaigns conducted for the CTBTO between 2008 and 2018.
    Baré J; Gheddou A; Kalinowski MB
    J Environ Radioact; 2023 Feb; 257():107053. PubMed ID: 36375403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved performance comparisons of radioxenon systems for low level releases in nuclear explosion monitoring.
    Haas DA; Eslinger PW; Bowyer TW; Cameron IM; Hayes JC; Lowrey JD; Miley HS
    J Environ Radioact; 2017 Nov; 178-179():127-135. PubMed ID: 28818645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atmospheric transport modelling of time resolved 133Xe emissions from the isotope production facility ANSTO, Australia.
    Schöppner M; Plastino W; Hermanspahn N; Hoffmann E; Kalinowski M; Orr B; Tinker R
    J Environ Radioact; 2013 Dec; 126():1-7. PubMed ID: 23917155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International challenge to predict the impact of radioxenon releases from medical isotope production on a comprehensive nuclear test ban treaty sampling station.
    Eslinger PW; Bowyer TW; Achim P; Chai T; Deconninck B; Freeman K; Generoso S; Hayes P; Heidmann V; Hoffman I; Kijima Y; Krysta M; Malo A; Maurer C; Ngan F; Robins P; Ross JO; Saunier O; Schlosser C; Schöppner M; Schrom BT; Seibert P; Stein AF; Ungar K; Yi J
    J Environ Radioact; 2016 Jun; 157():41-51. PubMed ID: 26998569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the usability of event zero time determinations using radioxenon isotopic activity ratios given the real atmospheric background observations.
    Yamba K; Kalinowski MB; Sanogo O
    J Environ Radioact; 2019 Nov; 208-209():106014. PubMed ID: 31323601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of fission and activation products in molten salt reactors and their potential impact on the radionuclide monitoring stations of the International Monitoring System.
    Johnson C; Slack JL; Sharma MK; Simpson CK; Burnett JL
    J Environ Radioact; 2021 Aug; 234():106625. PubMed ID: 33957486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioxenon spiked air.
    Watrous MG; Delmore JE; Hague RK; Houghton TP; Jenson DD; Mann NR
    J Environ Radioact; 2015 Dec; 150():126-31. PubMed ID: 26318775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection in subsurface air of radioxenon released from medical isotope production.
    Johnson C; Biegalski S; Haas D; Lowrey J; Bowyer T; Hayes J; Suarez R; Ripplinger M
    J Environ Radioact; 2017 Feb; 167():160-165. PubMed ID: 27843063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The workshop on signatures of medical and industrial isotope production - WOSMIP; Strassoldo, Italy, 1-3 July 2009.
    Matthews KM; Bowyer TW; Saey PR; Payne RF
    J Environ Radioact; 2012 Aug; 110():1-6. PubMed ID: 22307052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the capability to model the background and its uncertainty of CTBT-relevant radioxenon isotopes in Europe by using ensemble dispersion modeling.
    De Meutter P; Camps J; Delcloo A; Deconninck B; Termonia P
    J Environ Radioact; 2016 Nov; 164():280-290. PubMed ID: 27532672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third international challenge to model the medium- to long-range transport of radioxenon to four Comprehensive Nuclear-Test-Ban Treaty monitoring stations.
    Maurer C; Galmarini S; Solazzo E; Kuśmierczyk-Michulec J; Baré J; Kalinowski M; Schoeppner M; Bourgouin P; Crawford A; Stein A; Chai T; Ngan F; Malo A; Seibert P; Axelsson A; Ringbom A; Britton R; Davies A; Goodwin M; Eslinger PW; Bowyer TW; Glascoe LG; Lucas DD; Cicchi S; Vogt P; Kijima Y; Furuno A; Long PK; Orr B; Wain A; Park K; Suh KS; Quérel A; Saunier O; Quélo D
    J Environ Radioact; 2022 Dec; 255():106968. PubMed ID: 36148707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notes on radioxenon measurements for CTBT verification purposes.
    Saey PR; De Geer LE
    Appl Radiat Isot; 2005; 63(5-6):765-73. PubMed ID: 16005237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of radioxenon released from Southern Hemisphere medical isotope production facilities using measured air concentrations and atmospheric transport modeling.
    Eslinger PW; Friese JI; Lowrey JD; McIntyre JI; Miley HS; Schrom BT
    J Environ Radioact; 2014 Sep; 135():94-9. PubMed ID: 24811887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global radioxenon emission inventory based on nuclear power reactor reports.
    Kalinowski MB; Tuma MP
    J Environ Radioact; 2009 Jan; 100(1):58-70. PubMed ID: 19070405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated radioxenon monitoring for the comprehensive nuclear-test-ban treaty in two distinctive locations: Ottawa and Tahiti.
    Stocki TJ; Blanchard X; D'Amours R; Ungar RK; Fontaine JP; Sohier M; Bean M; Taffary T; Racine J; Tracy BL; Brachet G; Jean M; Meyerhof D
    J Environ Radioact; 2005; 80(3):305-26. PubMed ID: 15725505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and analysis of xenon isotopes for the comprehensive nuclear-test-ban treaty international monitoring system.
    Bowyer TW; Schlosser C; Abel KH; Auer M; Hayes JC; Heimbigner TR; McIntyre JI; Panisko ME; Reeder PL; Satorius H; Schulze J; Weiss W
    J Environ Radioact; 2002; 59(2):139-51. PubMed ID: 11900202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioxenon detections in the CTBT international monitoring system likely related to the announced nuclear test in North Korea on February 12, 2013.
    Ringbom A; Axelsson A; Aldener M; Auer M; Bowyer TW; Fritioff T; Hoffman I; Khrustalev K; Nikkinen M; Popov V; Popov Y; Ungar K; Wotawa G
    J Environ Radioact; 2014 Feb; 128():47-63. PubMed ID: 24316684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.